MedTrace Logo

Positron Emission Tomography-Computed Tomography (PET-CT) High-grade Glioma

NCT00643591 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 10

Last updated 2015-04-10

No results posted yet for this study

Summary

The objectives of the trial are:

* To determine the localisation within the primary tumor of the therapy resistant cells, before and during radiotherapy to determine a possible accurate boost volume.
* To determine changes during treatment intra- and extratumoral within the irradiated area.(Intratumoral: change of up-take - decrease, increase, change of localization/ Extratumoral: effects of temporal changes in up-take - e.g. due to oedema).

Conditions

  • Cerebral Astrocytoma, High Grade

Interventions

OTHER

imaging (dynamic PET-CT scan)

dynamic PET-CT scan

Sponsors & Collaborators

  • Maastricht University Medical Center

    collaborator OTHER

  • Maastricht Radiation Oncology

    lead OTHER

Principal Investigators

  • Brigitta Baumert, MD PhD · Maastricht Radiation Oncology

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-06-30
Primary Completion
2009-06-30
Completion
2010-06-30

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00643591 on ClinicalTrials.gov